MEDVi swaps PT-141 for apomorphine in compounded ED formula
The telehealth provider says its updated four-in-one compounded erectile dysfunction treatment replaces the peptide bremelanotide with apomorphine.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 16 16:40 ETSource: newswire.com
The wire
- 01MEDVi announced a reformulated 4-in-1 compounded ED treatment using apomorphine instead of the peptide PT-141.
- 02Peptide substitutions in compounded formulas reflect shifting supply and regulatory pressure on bremelanotide.
- 03No efficacy or safety comparison data was presented for the new formula.
From the source
Read at news.google.comMEDVi QUAD New Formula 2026: Apomorphine Replaces PT-141 in Updated 4-in-1 Compounded ED Treatment